• 1. Chemoenzymatic dynamic kinetic resolution of α-trifluoromethylated amines: influence of substitutions on the reversed stereoselectivity
  Guilin Cheng,Bo Xia,Qi Wu,Xianfu Lin RSC Adv. 2013 3 9820
• 2. Short syntheses of 1-substituted dibenzothiophene derivatives
  Erin N. Welsh,Katherine N. Robertson,Alexander W. H. Speed Org. Biomol. Chem. 2021 19 2000

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Application of 2,2,2-Trifluoro-N-methoxy-N-methylacetamide (CAS: 104863-67-4) in Chemical Biology and Pharmaceutical Research

2,2,2-Trifluoro-N-methoxy-N-methylacetamide (CAS: 104863-67-4) is a fluorinated acetamide derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including peptides, heterocycles, and fluorinated pharmaceuticals. Its unique trifluoromethyl group enhances metabolic stability and bioavailability, making it a valuable building block in drug discovery and development.

Recent studies have highlighted the role of 2,2,2-Trifluoro-N-methoxy-N-methylacetamide in facilitating efficient amide bond formation, a critical step in peptide synthesis. Researchers have demonstrated its utility in solid-phase peptide synthesis (SPPS), where it acts as a coupling reagent to improve yield and reduce racemization. Additionally, its compatibility with a wide range of protecting groups and solvents has made it a preferred choice for the synthesis of complex peptide architectures.

In the realm of medicinal chemistry, 2,2,2-Trifluoro-N-methoxy-N-methylacetamide has been employed in the design of novel protease inhibitors and kinase modulators. A 2023 study published in the Journal of Medicinal Chemistry reported the successful incorporation of this compound into a series of covalent inhibitors targeting SARS-CoV-2 main protease (Mpro). The resulting inhibitors exhibited enhanced binding affinity and selectivity, underscoring the potential of 104863-67-4 in antiviral drug development.

Beyond its applications in peptide and drug synthesis, 2,2,2-Trifluoro-N-methoxy-N-methylacetamide has also been explored as a fluorinating agent in organic transformations. Its ability to introduce trifluoromethyl groups into heterocyclic scaffolds has opened new avenues for the development of fluorinated pharmaceuticals, which often exhibit improved pharmacokinetic properties. Recent work published in Organic Letters demonstrated its efficacy in the trifluoromethylation of indoles and pyrroles, yielding compounds with potential anticancer activity.

Despite its promising applications, challenges remain in the large-scale production and handling of 2,2,2-Trifluoro-N-methoxy-N-methylacetamide. Researchers are actively investigating greener synthetic routes and safer handling protocols to address these issues. A 2024 study in Green Chemistry proposed a solvent-free mechanochemical synthesis of this compound, which not only improved yield but also reduced environmental impact.

In conclusion, 2,2,2-Trifluoro-N-methoxy-N-methylacetamide (CAS: 104863-67-4) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility in synthesis, coupled with its ability to enhance the properties of bioactive molecules, positions it as a critical component in the development of next-generation therapeutics. Ongoing research aims to further expand its applications and optimize its synthesis, paving the way for innovative discoveries in the field.

• 86455-17-6(2-fluoro-N-methoxy-N-methylacetamide)
• 142492-01-1(2,2-Difluoro-N-methoxy-N-methylacetamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)